Phillips 66 (PSX) Q2 earnings beat: refining margins, EBITDA, debt reduction and buybacks. Click to read my analysis for more details on the pros and cons.

MARKETS15M AGO

Iridium: A Merger-Arb Hold At Current Levels

Iridium (IRDM) rated Hold with $48 target amid Rocket Lab merger.

MARKETS17M AGO

Opus Genetics: A Resounding Study Success Merits A Higher Valuation

Opus Genetics (IRD) receives a Buy rating following >30% stock surge on positive Phase 1/2 data for OPGx-BEST1 in BEST1-related retinal diseases. Click to read.

MARKETS21M AGO

Shoe Station Q2: Not The Value Stock To Invest In Currently

Shoe Station Group Inc. stock plunged after weak Q2 earnings and lowered FY2026 guidance. Click for this SHOE earnings update.